ANTICOAGULANT SODIUM CITRATE SOLUTION, USP

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: fb53f2f9046583ae
Drug Approval Canada Name: ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
Product Name: ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
Status: Marketed
Status Date: 2023-10-31
Original Market Date: 2023-10-31
Din: 02529637
Drug Class: Human
Dosage Form: Solution
Route Of Administration: 0-Unassigned
Schedule: Ethical
Ahfs: 20:12.04.92
Atc Original: V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Atc Name: v 07 ac
Aig Number: 0100377001
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

SODIUM CITRATE

4 G / 100 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fb53f2f9046583ae

Type

Standard